Wikipedia:Philip Beales

Philip Beales is the co-founder and CEO of Axovia Therapeutics and a professor at the University College London Institute of Child Health. Beales co-founded Axovia Therapeutics with his partner Dr. Victor Hernandez in 2020. Dr. Beales is developing the first gene therapies to treat patients with ciliopathies such as the rare Bardet-Biedl syndrome (BBS).

In 2013 he presented the Ellison-Cliffe Lecture.